2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride
C17H26ClF3N4O2 — CID 119710712
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride
2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride (PubChem CID 119710712) has the molecular formula C17H26ClF3N4O2 and a molecular weight of 410.87 g/mol. Its IUPAC name is 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride.
Molecular Properties
| Compound Name | 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride |
|---|---|
| PubChem CID | 119710712 |
| Molecular Formula | C17H26ClF3N4O2 |
| Molecular Weight | 410.87 g/mol |
| Exact Mass | 410.17 |
| IUPAC Name | 2-(8-azabicyclo[3.2.1]octan-3-yl)-N-[4,4,4-trifluoro-3-hydroxy-3-(1-methylimidazol-2-yl)butyl]acetamide;hydrochloride |
| SMILES | Cl.Cn1ccnc1C(O)(CCNC(=O)CC1CC2CCC(C1)N2)C(F)(F)F |
| InChI | InChI=1S/C17H25F3N4O2.ClH/c1-24-7-6-22-15(24)16(26,17(18,19)20)4-5-21-14(25)10-11-8-12-2-3-13(9-11)23-12;/h6-7,11-13,23,26H,2-5,8-10H2,1H3,(H,21,25);1H |
| InChIKey | AQOVSKCCMCOZDT-UHFFFAOYSA-N |
| XLogP | 2.02 |
| TPSA | 79.18 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.87 |
| LogP ≤ 5 | 2.02 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119710712 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.